Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

136
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
136
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

160
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
160
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

147
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
147
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

246
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
246
Vascular Spasm01:16

Vascular Spasm

1.3K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary Peptidomic Signatures Predict Overall and Progression-Free Survival in Bladder Cancer.

Proteomics·2026
Same author

Renal Solitary Fibrous Tumor With Local Recurrence Following Complete Surgical Resection: A Case Report.

Cureus·2026
Same author

Delayed Diagnosis of Posterior Urethral Valves in a 14-Year-Old Adolescent.

Reports (MDPI)·2026
Same author

Penile Mondor Disease Following Circumcision: Diagnostic Insights from Color Doppler Ultrasound.

Diagnostics (Basel, Switzerland)·2026
Same author

Results of rotational thromboelastometry confirm venous thromboembolic risk prediction in urologic patients.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica·2026
Same author

Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate (HoLEP): A Systematic Review of Perioperative, Oncological, and Functional Outcomes.

Cancers·2025

Related Experiment Video

Updated: Jun 13, 2025

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
02:21

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease

Published on: March 15, 2024

592

Acute Phase Peyronie's Disease: Where Do We Stand?

Konstantinos Douroumis1, Konstantinos Kotrotsios1, Panagiotis Katsikatsos1

  • 1Department of Urology, National and Kapodistrian University of Athens, Athens, GRC.

Cureus
|September 17, 2024
PubMed
Summary

Peyronie's disease (PD) management focuses on conservative treatments during the acute phase, avoiding surgery. Current optimal strategies combine therapies like PDE5Is, ESWT, PTT, and intralesional injections.

Keywords:
acute phaseandrologymale sexual healthpenile curvaturepeyronie disease

More Related Videos

Vessel-sparing Excision and Primary Anastomosis
08:09

Vessel-sparing Excision and Primary Anastomosis

Published on: January 7, 2019

11.4K
Microscopic Replantation of Penile Glans Amputation Due to Circumcision
07:28

Microscopic Replantation of Penile Glans Amputation Due to Circumcision

Published on: June 3, 2022

18.6K

Related Experiment Videos

Last Updated: Jun 13, 2025

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
02:21

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease

Published on: March 15, 2024

592
Vessel-sparing Excision and Primary Anastomosis
08:09

Vessel-sparing Excision and Primary Anastomosis

Published on: January 7, 2019

11.4K
Microscopic Replantation of Penile Glans Amputation Due to Circumcision
07:28

Microscopic Replantation of Penile Glans Amputation Due to Circumcision

Published on: June 3, 2022

18.6K

Area of Science:

  • Urology
  • Andrology
  • Regenerative Medicine

Background:

  • Peyronie's disease (PD) involves penile fibrosis and curvature.
  • Micro-traumas and inflammation are key pathogenetic factors.
  • PD presents in acute and chronic phases, with pain characteristic of the acute stage.

Purpose of the Study:

  • To review conservative treatment options for acute phase Peyronie's disease.
  • To identify current optimal treatment strategies for acute PD.
  • To highlight the need for further research in acute PD management.

Main Methods:

  • Review of conservative treatment modalities for acute Peyronie's disease.
  • Discussion of oral, topical, intralesional therapies, ESWT, and PTT.
  • Synthesis of current evidence for combined treatment approaches.

Main Results:

  • Conservative treatments are recommended for acute phase PD to avoid surgical risks.
  • A combined strategy including PDE5Is, ESWT, PTT, and intralesional therapies is currently considered optimal.
  • Pain management is a primary goal during the acute phase.

Conclusions:

  • Optimal management of acute Peyronie's disease involves a multimodal conservative approach.
  • Further large-scale randomized controlled trials are essential to confirm the efficacy of various treatment options.
  • Avoiding surgery during the acute phase is crucial for better long-term outcomes.